Company research / TVTX
Travere Therapeutics, Inc. (TVTX)
- Sector Manufacturing
- Incorporated CA
- Fiscal year ends Dec 31
For the year ended 2025-12-31, Travere Therapeutics, Inc. reported revenue of $490.73M. Revenue grew 110.5% from the prior annual period.
Key ratios (year ended 2025-12-31)
-12.8%
Operating margin
-5.2%
Net margin
-22.2%
Return on year-end equity
110.5%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.